Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

The surface sampling program has returned consistent, positive magnetically recoverable DTR nickel values over a larger area ...

R-DXd showed a 50.5% objective response rate in platinum-resistant ovarian cancer, with a 5.6 mg/kg dose deemed optimal for further study. The safety profile was manageable, with 93.5% experiencing ...

Endomines Finland Plc - inside information - 15.10.2025 at 12:30 Inside Information: Endomines Reports High-Grade Gold Intercepts at Hosko Endomines Finland Oyj has completed the drilling program carr ...

Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed by ...

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant ...

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...

These data support the use of pembrolizumab plus weekly paclitaxel, with or without bevacizumab, as a new standard of care for patients with platinum-resistant, recurrent ovarian cancer,” said ...

Vanadiferous titanomagnetite (“VTM”) mineralization at Radar is comparable to global Fe–Ti–V systems such as Panzhihua (China ...

A home isn’t just made of walls and a roof; it’s built from memories, habits, and the everyday objects that fill its spaces.

Shenzhen, October 7, 2025– Fosi Audio, the fast-growing audio company redefining high-fidelity sound for everyday listeners, ...